EnWave (ENW) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
11 Jan, 2026Executive summary
Q4 2024 revenue rose to CAD 3.6 million ($3,634K), up 149% year-over-year, driven by a large-scale machine resale and higher royalties.
Net income from continuing operations reached CAD 588,000 ($588K) in Q4 2024, a $1,193K improvement year-over-year.
Management emphasized operational execution, expanding the sales pipeline, and a positive outlook for fiscal 2025.
Annual revenue for 2024 was $8,181K, down $3,182K from 2023 due to fewer machine sales, partially offset by higher royalties.
Gross margin for Q4 2024 was 40%, up from 29% in Q4 2023, but annual gross margin was 33%, down from 39% in 2023.
Financial highlights
Q4 2024 royalties were CAD 642,000 ($642K), a 69% increase year-over-year, with full-year royalties reaching CAD 2 million ($1,961K), up 34%.
Adjusted EBITDA for Q4 2024 was CAD 450,000 ($450K), compared to a loss of CAD 324,000 in Q4 2023; annual Adjusted EBITDA was a loss of $1,489K.
SG&A (including R&D) for Q4 2024 was CAD 1.3 million, up 26% year-over-year, mainly due to legal, travel, marketing, and trade show costs.
Net loss from discontinued operations for 2024 was $48K, a significant improvement from $4,933K loss in 2023.
Basic and diluted EPS from continuing operations was $0.01 for Q4 2024, compared to $(0.01) in Q4 2023.
Outlook and guidance
Anticipates continued royalty growth in fiscal 2025, driven by new large-scale machines and a strong commercial pipeline.
Several imminent large-scale machine order decisions are expected, with partners considering upgrades.
Ongoing investment in sales and marketing to drive further growth and expand international sales presence.
Management highlights strategy to expand royalty-bearing commercial licenses.
Forward-looking statements caution on risks, uncertainties, and assumptions affecting future performance.
Latest events from EnWave
- REV™ technology drives recurring royalties and global growth in food, pharma, and cannabis markets.ENW
Corporate presentation5 Mar 2026 - Revenue up 36% to CAD 1.6M, gross margin at 37%, and new license deals drive growth.ENW
Q1 202620 Feb 2026 - Doubling machine sales in 2025 could drive significant EBITDA and royalty growth.ENW
Planet MicroCap Showcase3 Feb 2026 - Accelerating royalty growth and global adoption position the business for scalable, high-margin expansion.ENW
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Accelerating royalty growth and global expansion position the business for positive EBITDA in 2026.ENW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Q2 2025 revenue surged 456%, gross margin hit 33%, and EBITDA turned positive.ENW
Q2 202527 Jan 2026 - Record royalties, margin rebound, and positive EBITDA highlight strong growth momentum.ENW
Q3 202423 Jan 2026 - Higher royalties and margins offset lower sales; losses narrowed and new deals signed.ENW
Q1 202526 Dec 2025 - Record revenue and profitability in FY2025 set the stage for continued growth in 2026.ENW
Q4 202515 Dec 2025